The Effect of Long-acting Muscarinic Antagonist on Airway Inflammation Through Leukotrienes

被引：0
|
作者：
Matsuyama, T. [1 ]
Machida, K. [1 ]
Matsuyama, H. [1 ]
Dotake, Y. [1 ]
Takagi, K. [1 ]
Inoue, H. [1 ]
机构：
[1] Kagoshima Univ, Dept Pulm Med, Grad Sch Med & Dent Sci, Kagoshima, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1300
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A Survey of Physicians' Perceptions About Using Long-Acting Muscarinic Antagonist for Hospitalized COPD Patients
    Nabeel, S.
    Siddique, H.
    Kumar, V.
    Barnes, M.
    Le, T.
    Haggerty, G.
    Rengarajan, H.
    Ng, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [42] A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease
    Masato Muraki
    Yuki Kunita
    Ken Shirahase
    Ryo Yamazaki
    Soichiro Hanada
    Hirochiyo Sawaguchi
    Yuji Tohda
    BMC Pulmonary Medicine, 21
  • [43] The role of long-acting muscarinic antagonist/long-acting β agonist fixed-dose combination treatment for chronic obstructive pulmonary disease in China: a narrative review
    Zhou, Ji'an
    Zhang, Jing
    Zhou, Min
    Hang, Jingqing
    Zhang, Min
    Han, Fengfeng
    Zhu, Huili
    JOURNAL OF THORACIC DISEASE, 2021, 13 (11) : 6453 - 6467
  • [44] A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease
    Muraki, Masato
    Kunita, Yuki
    Shirahase, Ken
    Yamazaki, Ryo
    Hanada, Soichiro
    Sawaguchi, Hirochiyo
    Tohda, Yuji
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [45] Long-acting muscarinic antagonist and long-acting beta 2-agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery
    Makino, Takashi
    Otsuka, Hajime
    Hata, Yoshinobu
    Koezuka, Satoshi
    Azuma, Yoko
    Isobe, Kazutoshi
    Sugino, Keishi
    Ebihara, Sitorlt
    Homma, Sakae
    Iyoda, Akira
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (05) : 647 - 652
  • [46] Long-acting muscarinic antagonist versus long-acting β2 agonist/corticosteroid for moderate to severe chronic obstructive pulmonary disease patients: Exacerbation risk assessment
    Yang, Sheau-Ning
    Ko, Hsin-Kuo
    Hsiao, Yi-Han
    Su, Kang-Cheng
    Chang, Yuh-Lih
    Huang, Hsin-Yi
    Perng, Diahn-Warng
    Chung, Mei-Ing
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (06) : 488 - 494
  • [47] Low Doses of Long-Acting β-Agonists/Long-Acting Muscarinic Agents with Large Effects The FLIGHT Study
    Donohue, James F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 192 (09) : 1028 - 1030
  • [48] REVIEW OF NALTREXONE, A LONG-ACTING OPIATE ANTAGONIST
    CRABTREE, BL
    CLINICAL PHARMACY, 1984, 3 (03): : 273 - 280
  • [49] Switching from long-acting beta-agonist and inhaled corticosteroid to long-acting beta-agonist and long-acting muscarinic antagonist for chronic obstructive pulmonary disease: a case report of inhaled corticosteroid withdrawal
    Lam, Jamie Chung Mei
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 15 - 18
  • [50] Long-acting Muscarinic Antagonist/Long-acting Beta-Agonist (LAMA/LABA) Combination Therapy Attenuates Carbachol-Induced Excitation-Contraction Coupling in Human Airway Smooth Muscle (HASM) Cells
    Karmacharya, N.
    Gao, K.
    Airen, P.
    Cao, G.
    Jester, W.
    Jude, J.
    Panettieri, R. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
12345